Search results

• 2021

  Comparison of Assays for Therapeutic Monitoring of Infliximab and Adalimumab in Patients With Inflammatory Bowel Diseases

  Papamichael, K., Clarke, W. T., Vande Casteele, N., Germansky, K. A., Feuerstein, J. D., Melmed, G. Y., Siegel, C. A., Irving, P. M. & Cheifetz, A. S., Apr 2021, In: Clinical Gastroenterology and Hepatology. 19, 4, p. 839-841.e2

  Research output: Contribution to journal › Short survey › peer-review

  • Assay 100%
  • Inpatient 100%
  • Infliximab 100%
  • Patient with Inflammatory Bowel Disease 100%
  • Adalimumab 100%
  13 Citations (Scopus)